Difference between revisions of "Resource:Cc6c04c8-d628-457a-a514-e050023340ec"

From The Embassy of Good Science
Line 2: Line 2:
 
|Resource Type=Cases
 
|Resource Type=Cases
 
|Title=Ethics, Human Rights and HIV Vaccine Trials in Low-Income Settings
 
|Title=Ethics, Human Rights and HIV Vaccine Trials in Low-Income Settings
|Is About=This is a factual case.  
+
|Is About=This fictional case describes the human rights and ethical implications of vaccine trails in low-income communities and countries. Two short, fictional scenarios are analyzed from both perspectives. The case revolves around two key points: the informed consent and comprehension of the research by the potential participants and the question to what extend persuasion by the trail conductor is justifiable.  
 
<references />
 
<references />
|Important Because=<br />
+
|Important Because=The number of vaccine development trails that takes place in low and lower-middle income countries increases.<ref>Grenham, A., & Villafana, T. (2017). Vaccine development and trials in low and lower-middle income countries: Key issues, advances and future opportunities. ''Human vaccines & immunotherapeutics'', ''13''(9), 2192–2199. <nowiki>https://doi.org/10.1080/21645515.2017.1356495</nowiki></ref> With this increase in trail conductance, the risk of exploitation of the local communities also rises. It is important to avoid exploitation and respect the right of autonomy of the inhabitants of these countries. Therefore, identification of the important ethical issues and the human rights at stake is needed. In this manner, the analysis presented in the current case may be a first step towards policies and regulations that protect the rights of inhabitants of the low and lower-middle income countries where vaccine trails take place.
<references />
+
|Important For=Researchers; Ethics committee members; Pharma Industry
|Important For=Researchers
 
 
}}
 
}}
 
{{Link
 
{{Link
Line 15: Line 14:
 
}}
 
}}
 
{{Tags
 
{{Tags
 +
|Has Timepoint=2012
 
|Has Location=Sub Saharan Africa
 
|Has Location=Sub Saharan Africa
|Has Virtue And Value=Respect
+
|Has Virtue And Value=Respect; Autonomy
 
|Has Good Practice And Misconduct=Informed consent; Vulnerable population
 
|Has Good Practice And Misconduct=Informed consent; Vulnerable population
 
|Related To Research Area=Clinical medicine
 
|Related To Research Area=Clinical medicine
 
}}
 
}}

Revision as of 15:31, 14 June 2021

Cases

Ethics, Human Rights and HIV Vaccine Trials in Low-Income Settings

What is this about?

This fictional case describes the human rights and ethical implications of vaccine trails in low-income communities and countries. Two short, fictional scenarios are analyzed from both perspectives. The case revolves around two key points: the informed consent and comprehension of the research by the potential participants and the question to what extend persuasion by the trail conductor is justifiable.

Why is this important?

The number of vaccine development trails that takes place in low and lower-middle income countries increases.[1] With this increase in trail conductance, the risk of exploitation of the local communities also rises. It is important to avoid exploitation and respect the right of autonomy of the inhabitants of these countries. Therefore, identification of the important ethical issues and the human rights at stake is needed. In this manner, the analysis presented in the current case may be a first step towards policies and regulations that protect the rights of inhabitants of the low and lower-middle income countries where vaccine trails take place.

For whom is this important?

Other information

When
Virtues & Values
Good Practices & Misconduct
Research Area
  1. Grenham, A., & Villafana, T. (2017). Vaccine development and trials in low and lower-middle income countries: Key issues, advances and future opportunities. Human vaccines & immunotherapeutics, 13(9), 2192–2199. https://doi.org/10.1080/21645515.2017.1356495
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
5.1.6